# A Study of the Selection and Peripheral Function of Human Insulin-Reactive T-cells in a Type 1 Diabetic Immune System

> **NIH NIH F31** · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2020 · $34,196

## Abstract

Project Summary
In Type 1 diabetes (T1D), beta cell antigen-reactive T-cells escape negative selection in the thymus, travel to
the periphery, and kill insulin-producing pancreatic beta cells. In healthy individuals, central and peripheral
immune tolerance mechanisms prevent this type of autoimmune attack. It is not known which level of tolerance
fails in cases of T1D. Introduction of an insulin-reactive T-cell receptor (TCR) derived from a T1D patient to the
periphery of humanized mice can initiate diabetes, consistent with the notion that escape of autoreactive T-cells
from negative selection promotes disease. On the other hand, beta cell antigen-reactive T-cells have also been
isolated from the blood of healthy control (HC) individuals, raising the possibility that defective peripheral
tolerance mechanisms may promote T1D. Genetic studies have identified over 40 risk variants for T1D, including
genes implicated in both central and peripheral tolerance mechanisms. We hypothesize that there are both
hematopoietic stem cell (HSC)-intrinsic and thymus-intrinsic genetic variants in T1D individuals that a)
lead to the failure of negative selection of diabetogenic T-cell receptors during T-cell development in the
thymus and, additionally or alternatively; b) alter the characteristics of autoreactive T-cells to increase
their diabetogenicity. We have established a Personalized Immune (PI) mouse model that allows us to
generate an adult human's immune system de novo in immunodeficient NOD/LtSz-scid IL2R gamma null mice
(NSG) mice receiving patient HSCs and a partially HLA-matched fetal thymus graft. We have also demonstrated
that the patient HSCs can be lentivirally transduced to express a specific TCR and subsequently used to
reconstitute NSG mice or human thymus tissue in thymic organ culture assays. With these techniques and with
access to HSC and thymus tissue from T1D and HC donors, we will study the thymic selection and subsequent
peripheral function of insulin-reactive TCRs expressed on T-cells derived from T1D HSCs and selected in a T1D
thymus. In these studies, we aim to determine if there is a genetically-predetermined defect in the central
tolerance mechanism of negative selection and/or peripheral immune tolerance mechanisms in T1D.

## Key facts

- **NIH application ID:** 10066743
- **Project number:** 1F31DK121377-01A1
- **Recipient organization:** COLUMBIA UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** Rachel Caroline Madley
- **Activity code:** F31 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $34,196
- **Award type:** 1
- **Project period:** 2020-07-01 → 2021-01-18

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10066743

## Citation

> US National Institutes of Health, RePORTER application 10066743, A Study of the Selection and Peripheral Function of Human Insulin-Reactive T-cells in a Type 1 Diabetic Immune System (1F31DK121377-01A1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10066743. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*